Personalized management of high blood pressure in Anhui, China

Not Applicable

• Conditions: Hypertension; Circulatory System

• Registration Number: ISRCTN10999269
• Lead Sponsor: ational Natural Science Foundation of China

Brief Summary

2021 protocol in https://pubmed.ncbi.nlm.nih.gov/33711941/ (added 15/03/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-17
• Last Update Posted: 30 March 2021
• Study Completion: 2025-07-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 3420

Inclusion Criteria

1. Aged =18 years
2. Living in the selected villages for =6 months/year
3. Diagnosed with hypertension

Exclusion Criteria

Previous diagnosis of mental illness, serious illness, or disability

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Systolic BP/Diastolic BP measured using mercury sphygmomanometer at baseline and every 12 months after baseline for 5 years

Secondary Outcome Measures

Name	Time	Method
<br> 1. Quality of life<br> 2. Occurrence of hypertension-related complications (such as cerebral hemorrhage, coronary heart disease, myocardial infarction, cerebral infarction)<br> 3. Healthcare utilization<br> 4. Scores of objective behaviors<br> All secondary outcome measures will be measured using structured questionnaires at baseline and every 12 months after baseline for 5 years<br>